Appili Financial Statements From 2010 to 2026

Stocks . Canada . 
Stock . Appili Therapeutics
APLI Stock  CAD 0.02  0.01  20.00%   
Appili Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Appili Therapeutics' valuation are provided below:
Gross Profit
100.4 K
Market Capitalization
3 M
Enterprise Value Revenue
74.6446
Revenue
100.4 K
Earnings Share
(0.02)
We have found one hundred twenty available fundamental signals for Appili Therapeutics, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Appili Therapeutics' prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 13th of February 2026, Enterprise Value is likely to grow to about 21.8 M, while Market Cap is likely to drop about 4.6 M.

Appili Therapeutics Total Revenue

109,734

Check Appili Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Appili Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 4.6 M, Depreciation And Amortization of 11.3 K or Interest Expense of 4.2 M, as well as many indicators such as Price To Sales Ratio of 40.48, Dividend Yield of 0.0 or Days Sales Outstanding of 5.7 K. Appili financial statements analysis is a perfect complement when working with Appili Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Appili Therapeutics Technical models . Check out the analysis of Appili Therapeutics Correlation against competitors.

Appili Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.6 M2.7 M4.9 M
Pretty Stable
Short and Long Term Debt Total14.8 M14.1 M4.1 M
Slightly volatile
Other Current Liabilities64.8 K68.2 K439 K
Slightly volatile
Total Current Liabilities19 M18 M5.2 M
Slightly volatile
Property Plant And Equipment Net16.3 K17.1 K46.9 K
Slightly volatile
Accounts Payable3.2 M4.7 M2.3 M
Slightly volatile
Cash1.1 M1.1 M3.2 M
Pretty Stable
Non Current Assets Total16.3 K17.1 K46.9 K
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Long Term Debt804.2 K846.5 K1.3 M
Slightly volatile
Cash And Short Term Investments1.1 M1.1 M3.5 M
Pretty Stable
Net Receivables1.2 M1.9 M1.1 M
Slightly volatile
Common Stock Shares Outstanding74.6 M139.5 M59.2 M
Slightly volatile
Long Term Debt Total804.2 K846.5 K1.3 M
Slightly volatile
Liabilities And Stockholders Equity2.6 M2.7 M4.9 M
Pretty Stable
Non Current Liabilities Total804.2 K846.5 K1.3 M
Slightly volatile
Capital Surpluse17.9 M17 M4.8 M
Slightly volatile
Other Current Assets219.6 K131.7 K154.4 K
Slightly volatile
Other Stockholder Equity17.9 M17 M5.5 M
Slightly volatile
Total Liabilities19.8 M18.9 M6.5 M
Slightly volatile
Total Current Assets2.6 M2.7 M4.8 M
Pretty Stable
Common Stock30.4 M48.7 M20.7 M
Slightly volatile
Property Plant Equipment16.3 K17.1 K46.9 K
Slightly volatile
Common Stock Total Equity15.8 M24.1 M15.6 M
Slightly volatile
Short and Long Term Debt14 M13.3 M2.7 M
Slightly volatile
Capital Stock36.7 M48.7 M24 M
Slightly volatile
Property Plant And Equipment Gross85.1 K74.6 K114.8 K
Slightly volatile

Appili Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization11.3 K12.1 K12.6 K
Pretty Stable
Selling General Administrative3.5 M3.3 M2.5 M
Slightly volatile
Selling And Marketing Expenses122.8 K129.3 K274.3 K
Slightly volatile
Other Operating Expenses318.2 K335 K5.7 M
Very volatile
Research Development7.8 M8.4 M5.6 M
Slightly volatile
Cost Of Revenue11.2 K12.3 K12.1 K
Very volatile
Total Operating Expenses318.2 K335 K5.6 M
Very volatile
Reconciled Depreciation11.7 K12.1 K15.6 K
Slightly volatile

Appili Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation128.7 K135.5 K434.8 K
Pretty Stable
Depreciation11.3 K12.1 K12.6 K
Pretty Stable
Capital Expenditures2 K2.1 K22.2 K
Slightly volatile
Total Cash From Financing Activities165.6 K174.3 K4.1 M
Very volatile
End Period Cash Flow1.1 M1.1 M3.2 M
Pretty Stable
Change To Netincome4.3 M4.1 M1.6 M
Slightly volatile
Begin Period Cash Flow80.8 K85 K3.1 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio40.4848.5978.4647
Slightly volatile
Days Sales Outstanding5.7 K5.5 K1.5 K
Slightly volatile
Average Payables2.8 M3 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue1.721.351.9391
Slightly volatile
Capex To Depreciation0.190.21.9297
Slightly volatile
EV To Sales14413769.5171
Pretty Stable
Inventory Turnover0.140.180.1801
Slightly volatile
Days Of Inventory On Hand2.2 K2.1 K2 K
Slightly volatile
Payables Turnover0.00280.00290.0091
Slightly volatile
Sales General And Administrative To Revenue26.8425.5715.9224
Pretty Stable
Research And Ddevelopement To Revenue68.9865.724.026
Slightly volatile
Capex To Revenue0.01490.02110.0105
Slightly volatile
Cash Per Share0.01110.01160.0824
Very volatile
Days Payables Outstanding136.6 K130.1 K75.9 K
Slightly volatile
Current Ratio0.210.222.8749
Slightly volatile
Receivables Turnover0.06570.06910.5911
Slightly volatile
Capex Per Share0.00.07.0E-4
Slightly volatile
Average Receivables1.3 M916.6 K1.4 M
Slightly volatile
Revenue Per Share9.0E-40.0010.0066
Very volatile
Interest Debt Per Share0.120.13030.05
Slightly volatile
Debt To Assets3.833.651.2771
Slightly volatile
Operating Cycle5.7 K5.5 K2.3 K
Slightly volatile
Days Of Payables Outstanding136.6 K130.1 K75.9 K
Slightly volatile
Ebt Per Ebit12.912.292.9736
Slightly volatile
Quick Ratio0.210.222.8637
Slightly volatile
Net Income Per E B T0.760.910.8656
Slightly volatile
Cash Ratio0.08550.091.9446
Slightly volatile
Days Of Inventory Outstanding2.2 K2.1 K2 K
Slightly volatile
Days Of Sales Outstanding5.7 K5.5 K1.5 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0243
Slightly volatile
Fixed Asset Turnover5.766.079.689
Slightly volatile
Debt Ratio3.833.651.2771
Slightly volatile
Price Sales Ratio40.4848.5978.4647
Slightly volatile
Asset Turnover0.02830.02980.0745
Slightly volatile
Gross Profit Margin0.780.880.9635
Slightly volatile

Appili Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.6 M4.9 M20 M
Slightly volatile
Enterprise Value21.8 M17.6 M21.1 M
Pretty Stable

Appili Fundamental Market Drivers

Forward Price Earnings2.3776
Cash And Short Term Investments1.2 M

About Appili Therapeutics Financial Statements

Appili Therapeutics investors utilize fundamental indicators, such as revenue or net income, to predict how Appili Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue54.2 K56.9 K
Total Revenue115.5 K109.7 K
Cost Of Revenue12.3 K11.2 K
Stock Based Compensation To Revenue 1.35  1.72 
Sales General And Administrative To Revenue 25.57  26.84 
Research And Ddevelopement To Revenue 65.70  68.98 
Capex To Revenue 0.02  0.01 
Ebit Per Revenue(1.71)(1.80)

Pair Trading with Appili Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Appili Stock

  0.36ETG Entree ResourcesPairCorr
  0.36NICU Magna MiningPairCorr
  0.34CU-PH Canadian UtilitiesPairCorr
  0.31RKR ROKMASTER Resources CorpPairCorr
  0.31BGI-UN Brookfield GlobalPairCorr
The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.
The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Appili Stock

Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY